| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US6204257 | EISAI INC | Water soluble prodrugs of hindered alcohols |
Jul, 2022
(1 year, 2 months ago) | |
Lusedra is owned by Eisai Inc.
Lusedra contains Fospropofol Disodium.
Lusedra has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Lusedra are:
- US6204257
Lusedra was authorised for market use on 12 December, 2008.
Lusedra is available in solution;intravenous dosage forms.
Lusedra can be used as sedative-hypnotic agent indicated for monitored anesthesia care (mac) sedation.
The generics of Lusedra are possible to be released after 01 July, 2022.
Drugs and Companies using FOSPROPOFOL DISODIUM ingredient
Market Authorisation Date: 12 December, 2008
Treatment: Sedative-hypnotic agent indicated for monitored anesthesia care (mac) sedation
Dosage: SOLUTION;INTRAVENOUS
LUSEDRA family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic